These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16408072)

  • 21. Enantioselective synthesis of derivatives and structure-activity relationship study in the development of NA255 as a novel host-targeting anti-HCV agent.
    Kawasaki K; Masubuchi M; Hayase T; Komiyama S; Watanabe F; Fukuda H; Murata T; Matsubara Y; Koyama K; Shindoh H; Sakamoto H; Okamato K; Ohta A; Katsume A; Aoki M; Aoki Y; Shimma N; Sudoh M; Tsukuda T
    Bioorg Med Chem Lett; 2013 Jan; 23(1):336-9. PubMed ID: 23164713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subproteomic study of hepatitis C virus replicon reveals Ras-GTPase-activating protein binding protein 1 as potential HCV RC component.
    Yi Z; Fang C; Pan T; Wang J; Yang P; Yuan Z
    Biochem Biophys Res Commun; 2006 Nov; 350(1):174-8. PubMed ID: 16996479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and molecular biology of HCV infection and hepatitis.
    Tang H; Grisé H
    Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HCV proteins suppress translation].
    Kato J; Kato N; Shiratori Y; Omata M
    Nihon Rinsho; 2001 Jul; 59(7):1254-8. PubMed ID: 11494533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Suppression of hepatitis C virus (HCV) replication with serine palmitoyltransferase inhibitor].
    Hirata Y; Sudoh M; Kohara M
    Yakugaku Zasshi; 2010 Feb; 130(2):157-61. PubMed ID: 20118637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease.
    Liu R; Abid K; Pichardo J; Pazienza V; Ingravallo P; Kong R; Agrawal S; Bogen S; Saksena A; Cheng KC; Prongay A; Njoroge FG; Baroudy BM; Negro F
    J Antimicrob Chemother; 2007 Jan; 59(1):51-8. PubMed ID: 17151003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon.
    Qureshi SA
    Med Res Rev; 2007 May; 27(3):353-73. PubMed ID: 16958135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
    Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
    Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization of the structures of the hepatitis C virus replication complex.
    Chan SC; Lo SY; Liou JW; Lin MC; Syu CL; Lai MJ; Chen YC; Li HC
    Biochem Biophys Res Commun; 2011 Jan; 404(1):574-8. PubMed ID: 21147066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
    Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
    Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis.
    Hirata Y; Ikeda K; Sudoh M; Tokunaga Y; Suzuki A; Weng L; Ohta M; Tobita Y; Okano K; Ozeki K; Kawasaki K; Tsukuda T; Katsume A; Aoki Y; Umehara T; Sekiguchi S; Toyoda T; Shimotohno K; Soga T; Nishijima M; Taguchi R; Kohara M
    PLoS Pathog; 2012; 8(8):e1002860. PubMed ID: 22916015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HCV replication by oxysterol-binding protein-related protein 4 (ORP4) through interaction with HCV NS5B and alteration of lipid droplet formation.
    Park IW; Ndjomou J; Wen Y; Liu Z; Ridgway ND; Kao CC; He JJ
    PLoS One; 2013; 8(9):e75648. PubMed ID: 24069433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft.
    Saxena V; Lai CK; Chao TC; Jeng KS; Lai MM
    J Virol; 2012 Apr; 86(8):4139-50. PubMed ID: 22301157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rescue of cell growth by sphingosine with disruption of lipid microdomain formation in Saccharomyces cerevisiae deficient in sphingolipid biosynthesis.
    Tani M; Kihara A; Igarashi Y
    Biochem J; 2006 Feb; 394(Pt 1):237-42. PubMed ID: 16225461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on sphingolipid biosynthesis.
    Loizides-Mangold U; Clément S; Alfonso-Garcia A; Branche E; Conzelmann S; Parisot C; Potma EO; Riezman H; Negro F
    PLoS One; 2014; 9(12):e115309. PubMed ID: 25522003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of host lipid raft proteome upon hepatitis C virus replication.
    Mannová P; Fang R; Wang H; Deng B; McIntosh MW; Hanash SM; Beretta L
    Mol Cell Proteomics; 2006 Dec; 5(12):2319-25. PubMed ID: 16943187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.
    Rodgers MA; Villareal VA; Schaefer EA; Peng LF; Corey KE; Chung RT; Yang PL
    J Am Chem Soc; 2012 Apr; 134(16):6896-9. PubMed ID: 22480142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.